Abacavir Sulfate CAS Number 188062-50-2

Abacavir sulfate, chemically defined as CAS number 188062-50-2, is a potent HIV medication. It inhibits the proliferation of the human immunodeficiency virus (HIV) by preventing the viral enzyme reverse transcriptase. This enzyme is crucial in the HIV life cycle, facilitating the virus to insert its genetic material into the host's DNA. Abacavir su

read more

Pharmacological Properties of Abacavir Sulfate (188062-50-2)

Abacavir sulfate acts as a nucleoside reverse transcriptase inhibitor administered in the therapy of human immunodeficiency virus disease. Its therapeutic properties involve the competitive inhibition of reverse transcriptase, an enzyme essential for HIV replication. Abacavir sulfate is a derivative that undergoes conversion to its active form, ca

read more

Leading API Manufacturer & Supplier

In today's rapidly evolving technological landscape, reliable and high-performance APIs are essential for enterprises of all sizes. A leading global API manufacturer and supplier delivers a comprehensive portfolio of cutting-edge APIs designed to meet the diverse needs of modern applications. With a strong commitment to quality, innovation, and cus

read more

Pharmacological Properties of Abacavir Sulfate (188062-50-2)

Abacavir sulfate is a nucleoside reverse transcriptase inhibitor. Its mechanism of action involves the competitive suppression of HIV-1 reverse transcriptase, an enzyme crucial for viral replication. Abacavir sulfate exerts its influence by being incorporated into the growing DNA chain during reverse transcription, leading to premature halt. This u

read more

India's Leading Nutraceutical API Manufacturer

India has firmly established itself as a global hub for dietary supplement ingredient production, particularly in the realm of Active Pharmaceutical Ingredients (compounds). Numerous Indian firms specialize in the specialized production of wellness active ingredients, serving both the local market and exporting globally. These businesses boast adva

read more